Just published 

• COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
• Anti-NASH Drug Development Hitches a Lift on PPAR Agonism 
• Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

Recent Grants

• IOF GEAR Brussels Liver Research to Valorisation Alliance (B-Liver)
• EU PANACHE: Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.
• H2020 TWINNING TWINALT: Towards excellence in alternative methods for toxicity assessment
• IRP Non-Animal Methodologies for Toxicity Testing of Chemical Compounds (TOXIN)

IVTD in the media

• Biovox: Belgian initiatives boosting animal-free innovation